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Abstract
Elevated concentrations of serum non-esterified fatty acids (NEFA), associated with maternal disorders such as obesity and
type II diabetes, alter the ovarian follicular micro-environment and have been associated with subfertility arising from
reduced oocyte developmental competence. We have asked whether elevated NEFA concentrations during oocyte
maturation affect the development and physiology of zygotes formed from such oocytes, using the cow as a model. The
zygotes were grown to blastocysts, which were evaluated for their quality in terms of cell number, apoptosis, expression of
key genes, amino acid turnover and oxidative metabolism. Oocyte maturation under elevated NEFA concentrations resulted
in blastocysts with significantly lower cell number, increased apoptotic cell ratio and altered mRNA abundance of DNMT3A,
IGF2R and SLC2A1. In addition, the blastocysts displayed reduced oxygen, pyruvate and glucose consumption, up-regulated
lactate consumption and higher amino acid metabolism. These data indicate that exposure of maturing oocytes to elevated
NEFA concentrations has a negative impact on fertility not only through a reduction in oocyte developmental capacity but
through compromised early embryo quality, viability and metabolism.
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Introduction
Up-regulated lipolysis, a feature of metabolic disorders such as
obesity and type II diabetes, results in increased plasma non-
esterified fatty acid (NEFA) concentrations [1–4]. It is well
established that elevated NEFA concentrations are cytotoxic for
several cell types such as Leydig cells [5], nerve growth factor
differentiated cells [6] and hepatocytes [7]. Furthermore, exposure
of pancreatic b-cells to elevated NEFA concentrations impairs
insulin secretion and is considered as an important factor in the
pathogenesis of diabetes [8].
Using a bovine model we have demonstrated that elevated
serum NEFA concentrations are reflected in the follicular fluid of
the pre-ovulatory ovarian follicle [4] and can directly affect the
granulosa cell viability and steroidogenesis [3,9] as well as the
developmental capacity of the oocyte [3,4,10]. In the human,
saturated NEFA, such as Palmitic Acid (PA) and Stearic Acid (SA),
suppress granulosa cell survival in a time-and-dose-dependent
manner [11], which might impair fertility.
Epidemiological studies have shown that lipolysis-linked mater-
nal metabolic disorders, such as obesity and type II diabetes [1,2],
are potential risk factors for reproductive disorders [12,13], which
could, at least in part, be related to early pregnancy loss [14,15].
As such, obesity in women not only increases the risk of
miscarriage but impairs the outcome of assisted reproductive
technologies [16,17,18].
It is widely acknowledged that appropriate oocyte development
governs several sequential and critical steps in meiosis, fertilization
and early cleavage [19–21]. Furthermore, molecular events during
oogenesis impact on the subsequent activation of the embryonic
genome, manifested later in embryogenesis [22–24]. However, the
extent of the relationship between these maternal metabolic
disorders and subfertility is unclear.
In the present study, we hypothesized that elevated NEFA
concentrations are a key metabolic factor in the relationship
between maternal metabolic disorders and subfertility, through a
negative effect on the oocyte. To address this, we have used a
bovine oocyte in vitro culture model to investigate whether
elevated NEFA concentrations during bovine oocyte maturation
influence subsequent embryo phenotype.
We report that elevated NEFA concentrations, specifically Oleic
Acid (OA), Palmitic Acid (PA) and Stearic Acid (SA), during
oocyte maturation have negative consequences for the resulting
preimplantation embryo, measured 8 days later at the blastocyst
stage. These include altered blastocyst gene expression and
reduced embryo quality, determined in terms of energy and
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amino acid metabolism; known markers of embryo viability. Our
data provide evidence of a mechanism for metabolic deregulation
appearing in the preimplantation embryo as a consequence of
elevated NEFA concentrations during oocyte maturation and help
to explain the higher rate of early pregnancy loss and miscarriage
[15,25] observed in women suffering metabolic disorders.
Results
Developmental Competence of Oocytes Matured in the
Presence of elevated NEFA
Supplementing maturation medium with different combinations
of NEFA had no significant effect on cleavage rates but based on
the odds ratios, maturing oocytes in medium with elevated Stearic
Acid (HIGH SA) or in medium supplemented with a combination
of elevated Stearic Acid (SA), Palmitic Acid (PA) and Oleic Acid
(OA) concentrations (HIGH COMBI) resulted in a significant
reduction in the number of oocytes reaching the blastocyst stage at
day 7 post insemination (p.i.) (P,0.05). The HIGH COMBI
treatment also reduced the number of cleaved zygotes reaching the
blastocyst stage compared with the control group (P,0.01). The
capacity of cleaved zygotes to become blastocysts tended to be
lower in the HIGH SA group (P=0.06) compared with the control
group. The data of the effects of HIGH SA and HIGH COMBI
exposure during maturation on developmental competence are
presented in Table 1.
Cell Number and Apoptotic Cell Index in Bovine
Blastocysts Arising from Oocytes Matured in the
Presence of elevated NEFA
Total blastocyst cell number was significantly lower in the
HIGH COMBI (104.7626.1) and the HIGH SA (105.4624.7)
group compared with their control counterparts (125.8629.4)
(P,0.05). Furthermore, the apoptotic cell index was significantly
higher in the HIGH SA embryos (0.1860.08) compared with the
control (0.0960.05) and the HIGH COMBI embryos (0.1460.12)
(P,0.05). Data are listed in Table 1.
Expression Patterns of Key Genes in Bovine Blastocysts
Arising from Oocytes Matured in the Presence of
elevated NEFA
We next investigated the expression of key genes representative
of cellular processes linked to apoptosis, development, quality and
metabolism in the blastocyst. Surprisingly, the expression pattern
of many of these genes did not differ between embryos arising
from oocytes maturated with HIGH SA or the controls (Figure 1).
However, these data did indicate differences in regulation of DNA
methylation and glucose transport; both DNMT3A and SLC2A1
were up-regulated in blastocysts originating from oocytes matured
under HIGH COMBI conditions compared with the control
group (P,0.05). The expression of the IGF2R gene was up-
regulated in both groups matured under either HIGH SA or
HIGH COMBI conditions, compared to the control group
(P,0.05, Figure 1).
Amino Acid Metabolism of Blastocysts Originating from
NEFA-exposed Oocytes
As shown in Figure 2A, blastocysts arising from oocytes matured
in the presence of all three NEFA had a significantly elevated
amino acid consumption (P,0.01), production (P,0.05) and
overall turnover (P,0.01) compared with control embryos. HIGH
SA embryos displayed significant higher amino acid consumption
(P,0.01) and turnover (P,0.05) compared with control embryos
(Figure 2A).
The profiles of individual amino acids showed that significantly
higher levels of serine (P,0.01), histidine (P,0.01) and threonine
(P,0.05) were depleted from the culture medium containing
blastocysts derived from HIGH SA oocytes compared with control
and HIGH COMBI embryos, whereas more valine (P,0.05) was
depleted by HIGH COMBI blastocysts compared with control
embryos (Figure 2B). Glycine concentrations decreased in the
medium containing blastocysts from HIGH SA-exposed oocytes,
suggesting consumption of glycine, whereas control and HIGH
COMBI embryos showed net glycine production (P,0.05). Chi
square tests revealed that there were no significant differences in
developmental stage among treatment groups. Therefore, devel-
opmental stage can be excluded as possible confounder.
Key Processes of ATP Production in Blastocysts Arising
from Oocytes Exposed to NEFA
Given the observations that exposing oocytes to elevated NEFA
impacted on blastocyst quality, gene expression patterns and
amino acid metabolism, we next investigated the oxygen
consumption by these embryos. Using a non-invasive real time
assay of oxygen consumption, we found that blastocysts arising
from oocytes matured under HIGH COMBI conditions con-
sumed significantly less oxygen than control embryos (P,0.05,
Figure 3A). There was no significant difference in oxygen
Table 1. NEFA exposure of bovine oocytes significantly reduced the oocyte developmental competence and the quality of the
resultant blastocysts.
n (%) CONTROL HIGH SA HIGH PA HIGH OA
Oocytes 240 255 243 286
Cleaved 133 (55.4) 126 (52.1) 155 (63.8) 194 (67.8)
Blastocysts from
Oocytes matured
60 (25.0)a 45 (18.6)b 42 (17.3) b 64 (22.4) a
Blastocysts from cleaved zygotes 60 (45.1)a 45 (35.7)a 42 (27.1) b 64 (33.0)b
Blastocyst’s cell
number ± SD
125.8629.4 a 105.4624.7b 118.5634.5 a 122.7623.9 a
Blastocyst’s apoptotic cell ratio ± SD 0.0960.05a 0.1860.08b 0.2060.12b 0.1660.08 b
Oocytes (n = 1024; three replicates) were matured in maturation medium supplemented with 1) physiological NEFA = control (150 mM of total NEFA, i.e. OA, SA and
PA); 2) elevated Stearic Acid = HIGH SA (75 mM SA); 3) elevated Palmitic Acid = HIGH PA (150 mM PA) and 4) elevated Oleic Acid = HIGH OA (200 mM OA). Data marked
with different superscripts per row are significantly different between treatments (P,0.05).
doi:10.1371/journal.pone.0023183.t001
Effect of Elevated NEFA during Oocyte Maturation
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consumption between the HIGH SA and the control group or
between HIGH SA and HIGH COMBI embryos. We also
determined the consumption of pyruvate, glucose and lactate by
blastocysts originating from oocytes matured in the presence of
NEFA. HIGH COMBI embryos consumed significantly less
pyruvate and glucose when compared with control embryos
(P,0.05, Figure 3B). By contrast, the HIGH COMBI embryos
consumed significantly more lactate compared with the control
group (P,0.05, Figure 3B). There was no significant difference in
the level of pyruvate, glucose or lactate consumption between the
HIGH SA and the control embryos. Chi square tests revealed that
there were no significant differences in developmental stage among
treatment groups. Developmental stage can therefore be excluded
as a possible confounder.
Discussion
Elevated serum NEFA concentrations, arising from up-regulat-
ed lipolysis, have been implicated as a key factor in the association
between metabolic imbalances, cellular dysfunction and related
pathologies [5–8]. In this context, we demonstrate, using a bovine
model, that elevated NEFA concentrations during oocyte
maturation have a profound negative impact on embryo quality;
effects which persist some seven days after removal of NEFA
exposure, in terms of blastocyst formation, viability, metabolism
and gene transcription.
Support for the bovine as model of early mammalian
reproduction, especially of the human, has grown steadily over
the last decade. The human and bovine are single ovulators and
there are close similarities between human and bovine ovarian
function and oocyte characteristics, in contrast to major
differences in ovarian physiology and reproductive function
between rodents and humans [26]. Bovine and human embryos
are remarkably similar with respect to microtubule timing of
genome activation, metabolic requirements, interactions with the
culture medium and duration of preimplantation development
[27–29], which makes the cow an excellent model for human
reproductive research.
Our data show that elevated NEFA exposure during oocyte
maturation does not impair the ability of zygotes to reach the 2-
cell stage. However, there is a reduction in the number of the
HIGH NEFA-exposed oocytes capable of forming blastocysts. In
bovine and human embryos, the developmental processes of the
first 3-to-4 cleavage divisions occur under the control of
maternally-derived mRNAs and proteins stored in the oocyte,
until major embryonic genome activation (EGA) occurs at the 8–
16 cell stage. The reduction in blastocysts formed indicates that
NEFA-exposure during oocyte development has a significant
negative impact on post-genome activated development as well as
on the pattern of gene transcription after EGA. Data from recent
studies on an obese female mouse model [30,31] lend further
support to the proposition that elevated NEFA concentrations
contribute to the reduced fertility seen in females with compro-
mised metabolic status.
The total cell number in blastocysts from HIGH NEFA-exposed
oocytes was significantly reduced and the corresponding apoptotic
cell ratio increased, compared with control counterparts. It is
generally recognized that saturated NEFA, such as PA (C16:0) and
SA (C18:0), can directly exert negative effects on cell viability
[4,5,11]. In the present work, apoptotic cell ratio was significantly
higher in blastocysts from oocytes matured in HIGH SA medium
compared with those originating from oocytes matured in HIGH
COMBI or control medium. One interpretation of these findings
is that the unsaturated OA (C18:1), present in the HIGH COMBI
mixture, may compensate for the negative effects induced by the
saturated NEFA (PA and SA) in the COMBI mixture. This
proposition is broadly in line with the recent findings of Aardema
Figure 1. Expression patterns of key genes are altered in bovine blastocysts arising from oocytes matured in the presence of
elevated NEFA. Blastocysts were derived from oocytes matured under control, HIGH SA and HIGH COMBI conditions (n = 192; five replicates). Bars
with different superscripts are significantly different between treatments with P,0.05.
doi:10.1371/journal.pone.0023183.g001
Effect of Elevated NEFA during Oocyte Maturation
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et al. [10], who recognized that OA prevents detrimental effects of
saturated fatty acids.
NEFA exposure during oocyte maturation also affected the gene
expression pattern of the resulting blastocysts. A significant
increase in relative mRNA abundance of the HIGH COMBI
embryos was found for the SLC2A1 gene; a classic indication of
cellular stress [32]. Furthermore, the DNMT3A gene was
significantly up-regulated in HIGH COMBI blastocysts. This
gene encodes the de novo DNA methyltransferase whose regulation
is essential during preimplantation development for the proper
establishment of epigenetic marks. Among the epigenetic events
occurring during preimplantation development, the establishment
of genomic imprinting is crucial for subsequent placentation and
embryo development. IGF2R is a well known maternal imprinted
gene whose dysregulation causes perturbed placentation and fetal
growth [33–35]. In this regard, we observed that this gene was
significantly up-regulated in HIGH COMBI embryos compared
with the other treatments in the current study. No differences were
found in the relative mRNA abundance of apoptosis related genes,
such as BAX, SHC1 and TP53, which may indicate that the
increased apoptotic cell index observed in blastocysts may have
originated earlier in development. Moreover, it has been proposed
that translational and post-translational regulation of apoptosis
related genes in embryos appears to be more important than
transcriptional regulation [36].
In 2002, the ‘quiet embryo hypothesis’ was presented [37],
which states that the most viable early embryos exhibit a ‘quieter’
metabolism, well-illustrated with regard to amino acids. This
general pattern has been reported for bovine [38], porcine [39]
and human embryos [40] and has been suggested as a general
Figure 2. Amino acid metabolism of blastocysts originating from NEFA-exposed oocytes is compromised. A. Amino acid ‘turnover’ of
day 7 blastocysts as calculated by summing all amino acids produced and consumed on a per-embryo basis. Comparison was done between
blastocysts (n = 135; three replicates) derived from oocytes matured under control, HIGH SA and HIGH COMBI conditions. B. Overall mean profiles of
individual amino acids by blastocyst in the three treatments. Bars with different superscripts are significantly different between treatments (P,0.05).
doi:10.1371/journal.pone.0023183.g002
Effect of Elevated NEFA during Oocyte Maturation
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marker of embryo viability. Moreover, data on amino acid
metabolism in cleavage stage embryos are predictive of the ability
to form a blastocyst [38], with elevated metabolism indicating
reduced embryo competence. We therefore determined the amino
acid profiles of blastocysts arising from oocytes matured under the
NEFA conditions. Our findings indicated that blastocysts from
HIGH SA and HIGH COMBI had increased amino acid
metabolism and were most likely to be less viable than the
controls. The observation that in HIGH SA embryos the increased
amino acid metabolism was accompanied by an increase in
nuclear fragmentation, reflected in the higher apoptotic cell ratio,
corroborates previous findings in bovine blastocysts that an
elevated metabolism is associated with DNA damage [41].
It is increasingly recognized that oocyte and embryo metabolism
are closely linked with subsequent developmental capacity [42].
The consumption of oxygen provides an indicator of global
metabolic activity [43] and has previously been identified as an
important viability indicator for bovine embryos [32]. In contrast
with the up-regulated amino acid metabolism, we observed a
reduced oxidative metabolism in the HIGH SA and HIGH
COMBI embryos suggesting that oxygen consumption must be at
a certain threshold to sustain appropriate levels of ATP, since
chronically low ATP content can be responsible for implantation
failure in seemingly normal human embryos [44,45]. Our data in
the bovine are broadly in line with the findings of Lopes et al. [46]
that bovine blastocysts capable to giving rise to a pregnancy post-
transfer have values for oxygen consumption in the mid range of
the distribution and that a decrease in oxygen consumption is not
conducive to embryo viability. Both the reduced oxygen
consumption in HIGH SA and HIGH COMBI embryos and
the concomitant reduction in pyruvate and glucose consumption
in the same embryos (Figure 3) strongly suggest a drop in the rate
of oxidative phosphorylation. Unusually, all of the blastocysts in
the current work removed significant amounts of lactate from the
medium, most probably due to the low amounts of glucose in our
culture medium only present in the fetal calf serum. Lactate can
serve as an alternative energy source and may sustain normal
development to the blastocyst stage when glucose availability is low
[47,48].
Surprisingly, HIGH COMBI embryos consumed significantly
more lactate compared with control embryos. One explanation for
this might be that NEFA exposure results in an imbalance of the
intracellular oxidation-reduction (REDOX) potential, as previous-
ly reported [49,50]. Lactate has been recognized as a strong
cytosolic reductant in mouse oocytes [51] and may thus be
consumed by the HIGH COMBI embryos in our study to act as
REDOX-regulator in the face of metabolic stress. Lactate can be
converted by Lactate Dehydrogenase (LDH) into pyruvate, which
may then enter the tricarboxylic acid cycle after conversion to
oxaloacetate [52,53], with the concomitant regeneration of
NADH [47]. Alternatively, we observed elevated alanine produc-
tion in HIGH COMBI embryos. It is plausible that the excess in
lactate-derived pyruvate may be converted preferentially in the
cytosol to alanine by alanine aminotransferase [54].
Such an alteration in REDOX status may affect the activity of
REDOX sensitive transcription factors; for example, the amount
of SLC2A1 mRNA and the REDOX state are directly associated
[48,55]. Elevated Reactive Oxygen Species (ROS) concentrations
are known to up-regulate SLC2A1 transcription [32]; a pattern we
have observed in the present study. Despite the increased
expression of SLC2A1, also known as the facilitated glucose
transporter 1, there was no difference in the glucose consumption
by HIGH COMBI embryos; indeed there was no detectable
glucose consumption by embryos in this group. SCL2A1 up-
regulation in the absence of glucose uptake could be caused by a
failure in the SLC2A1 protein production or impairment in the
Figure 3. Key processes of ATP production are significantly altered in blastocysts arising from oocytes exposed to NEFA. A. Mean
oxygen consumption of day 7 blastocysts. Blastocysts (n = 66; three replicates) were derived from control-, HIGH SA- and HIGH COMBI-exposed
oocytes. Different superscripts indicate significant differences between treatments (P,0.05). B. Mean pyruvate, glucose and lactate consumption of
blastocysts. Blastocysts (n = 84; five replicates) originated from oocytes matured in control, HIGH SA and HIGH COMBI maturation medium. Different
superscripts indicate significant differences between treatments (P,0.05).
doi:10.1371/journal.pone.0023183.g003
Effect of Elevated NEFA during Oocyte Maturation
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glucose transport mechanisms. Alternatively, the decreased
glucose uptake in HIGH COMBI embryos may be considered
in terms of the glucose:fatty acid cycle [56], that, in cardiac cells
provision of NEFA, promotes fatty acid oxidation and inhibits
glucose oxidation.
In conclusion, our data show that maternal metabolic
conditions, associated with elevated NEFA during oocyte matu-
ration, may compromise fertility through a reduction in oocyte
developmental competence and the viability of the subsequent
embryo.
In highlighting the metabolic problems associated with obesity
and their potential relationship with subfertility, our findings are
consistent with public health recommendations which emphasise
the importance of women being at healthy weight before starting a
pregnancy.
Methods
For full details, see Materials and Methods S1, S2, S3, and
Table S1.
Composition of the Oocyte Maturation Treatments
The types and concentrations of free fatty acids used in the
present study are based on bovine in vivo studies [4] and are
physiologically appropriate, since circulating free fatty acid
concentrations in women suffering lipolysis-linked metabolic
disorders, including obesity [57,58], are very similar to NEFA
concentrations detected in bovine during an episode of up-
regulated lipolysis [4].
Standard serum-free maturation systems are devoid of fatty
acids, although the physiological environment, in which the oocyte
matures in vivo, contains physiological, basal concentrations of
NEFA [4]. In order to improve the relevance of our in vitro model,
we therefore used a maturation medium supplemented with basal
NEFA concentrations as control medium. We showed that
inclusion of physiological concentrations of the key NEFA in
maturation media formulations (three replicates; 595 oocytes) does
not affect developmental competence compared to standard
serum-free maturation media (P.0.1, details in Table 2).
In preliminary experiments, we identified Stearic Acid (SA) as
the most toxic NEFA for oocyte developmental competence
(Table 1). The effect of elevated Palmitic Acid (PA) concentrations
on developmental competence revealed similar findings as for
elevated Stearic Acid (SA) treatment, though less pronounced
(Table 1), supporting the findings of our previous study [4].
Elevated Oleic Acid (OA) treatment had no influence on
developmental competence nor on total blastocyst cell number;
only the blastocyst apoptotic cell index was significantly elevated
after OA treatment during oocyte maturation.
For additional experiments we therefore focussed on the HIGH
SA and the HIGH COMBI treatments. The following NEFA
treatments were used in the present study:
1. control = physiological NEFA concentrations (150 mM total
NEFA comprising 25 mM SA, 50 mM PA and 75 mM OA).
2.HIGH SA = elevated stearic acid concentrations (75 mM SA).
3.HIGH COMBI = combination of elevated NEFA concen-
trations (425 mM total NEFA, comprising 75 mM SA, 150 mM
PA and 200 mM OA).
Preparation of NEFA Treatments
All chemicals were purchased from SigmaH, unless otherwise
stated. SA, PA and OA were dissolved in a stock solution of pure
ethanol at concentrations of 25, 150 and 200 mM, respectively.
These ethanol stock solutions were vortex-mixed for 4 min and
diluted in working solutions to obtain the desired final concentra-
tion in maturation medium. The serum-free maturation medium
consisted of TCM199 supplemented with 0.75% BSA free of fatty
acids, 0.4 mM glutamine, 0.2 mM sodium pyruvate, 0.1 mM
cysteamine, 50 mg/mL gentamycin and murine epidermal growth
factor (mEGF, 20 ng/ml). All treatments were vigorously shaken
for 45 min and filter-sterilised under aseptic conditions.
In Vitro Embryo Production
In vitro production procedures were performed as previously
described [59], using immature oocytes retrieved from cows
collected within 2h of slaughter. For details refer to Materials and
Methods S1, S2, S3, and Table S1.
Oocyte Developmental Competence Assessment.
Cleavage (2 days post insemination (p.i.)), and blastocyst rates (7
days p.i.) were defined as the number of cleaved zygotes or formed
blastocysts per oocyte matured, respectively. The number of
blastocysts from cleaved zygotes was also recorded.
Measurement of Blastocyst Cell Number and Apoptotic
Cell Index
Cell number and apoptotic cell index (number of apoptotic cells
over total cell count) were assessed by staining normal and
expanded day 7 blastocysts with propidium iodide (PI) and with
terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL), respectively, as described [60].
Blastocyst RNA Extraction, Reverse Transcription and
Quantification of mRNA Transcript Abundance
Molecular biology procedures were carried out as previously
described [61]. See details in Material and Methods S1, S2, S3
and Table S1.
Amino Acid Profiling of Blastocysts
The amino acid content of spent culture media containing day 7
blastocysts was determined by reverse-phase HPLC as previously
described [38]. Details in Materials and Methods S1, S2, S3
and Table S1.
Table 2. Validation of a physiological relevant control
medium.
n (%)
standard serum-free
maturation medium
physiologically relevant
control medium
Oocytes 291 304
Cleaved 222 (76.2) a 179 (64.8) a
Blastocysts from
Oocytes matured
88 (30.2) a 89 (29.3) a
Blastocysts from
Cleaved zygotes
88 (39.6) a 89 (49.7) a
Cleavage rate at day 2 p.i., number of formed blastocysts at day 7 p.i. relative to
the number of matured oocytes or to the number of cleaved zygotes. Oocytes
(n = 595; three replicates) were matured in standard serum-free maturation
medium devoid of all fatty acids [59] and in physiologically relevant, NEFA
containing maturation medium with physiological, non toxic NEFA
concentrations ( = control medium used in this study: 150 mM of total NEFA, i.e.
OA, SA and PA). Data marked with different superscripts per row are
significantly different between treatments (P,0.05).
doi:10.1371/journal.pone.0023183.t002
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Oxygen Consumption Analysis of Blastocysts
Individual blastocysts day 7 p.i. were loaded into a PCR Glass
micropipette (Drummond) and allowed to respire for 30 min to
form an oxygen gradient. This oxygen gradient was measured in
real time using a nanorespirometer (Unisense) and converted to
oxygen consumption rate using SensorTrace Pro (Unisense)
according to a previous study [62].
Pyruvate, Lactate and Glucose consumption
Day 7 blastocysts were cultured individually for 3h in 4 ml
droplets of modified SOF medium alongside empty control
droplets. After the incubation period, the embryos were removed
and spent culture droplets frozen at280uC until analysis. Glucose,
lactate and pyruvate utilization was determined by ultrafluoro-
metric assays of spent medium as previously described [63].
Statistical Analyses
All statistical procedures were carried out with SPSS 15.0 (for
Windows, Chicago, IL, USA), unless otherwise stated. Cleavage
and blastocyst rates were compared between the three treatments
using a binary logistic regression model. For the other parameters
a mixed model ANOVA, taking treatment as fixed factor and
replicate as random factor, was used to compare differences
between the three groups. No data transformations were necessary
for inequality of variance between groups or for achieving
normality for any data with the exception of amino acid
metabolism. Chi square tests were used to analyze the effect of
blastocyst developmental stage on oxygen, glucose, pyruvate and
amino acid profiles. Relative transcript abundance was analyzed
using the SigmaStat (Jandel Scientific) software package using one-
way ANOVA with multiple pair-wise comparisons using Student-
Newman-Kleus method post-hoc.
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